Acquisition History / Artivion / Endospan
Artivion Acquires Endospan
Announced May 18, 2026 — $335M
What happened
Endospan is an Israeli medtech company whose aortic repair system received FDA approval, triggering Artivion's long-held acquisition option. The deal is worth up to US$335M.
- Acquirer
- Artivion
- Target
- Endospan
- Announced
- May 18, 2026
- Price
- $335M
- Industry
- Aortic repair medical devices
- Buyer type
- Strategic acquirer
- Status
- Announced, not yet closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Artivion acquire Endospan?
Artivion acquired Endospan on May 18, 2026. This was Artivion's 1st publicly tracked acquisition out of 1 we have on record.
How much did Artivion pay for Endospan?
Artivion paid $335M for Endospan.
What does Endospan do?
Endospan is an Israeli medtech company whose aortic repair system received FDA approval, triggering Artivion's long-held acquisition option. The deal is worth up to US$335M.
What other Aortic repair medical devices companies has Artivion acquired?
Endospan is Artivion's only publicly tracked acquisition in Aortic repair medical devices so far.